Carregant...
An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokinetics
PD98059 is a reversible MEK inhibitor that we are investigating as a potential treatment for neurochemical changes in the brain that drive neurohumoral excitation in heart failure. In preliminary studies in a rat model that closely resembles human heart failure, we found that PD98059 gains access to...
Guardat en:
| Publicat a: | Drug Deliv Transl Res |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7647946/ https://ncbi.nlm.nih.gov/pubmed/32378175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13346-020-00758-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|